Literature DB >> 34906950

Danielle O'Toole1.   

Abstract

Entities:  

Year:  2021        PMID： 34906950      PMCID： PMC8670651          DOI： 10.46747/cfp.6712e326

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  19 in total

1.  Update on acetylsalicylic acid for primary prevention of cardiovascular disease: Not initiating is not the same thing as discontinuing.

Authors:  Christine Truong
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

2.  The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver.

Authors:  Hemant Shah; Marc Bilodeau; Kelly W Burak; Curtis Cooper; Marina Klein; Alnoor Ramji; Dan Smyth; Jordan J Feld
Journal:  CMAJ       Date:  2018-06-04       Impact factor: 8.262

Review 3.  Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel.

Authors:  Jane E Wilcox; James C Fang; Kenneth B Margulies; Douglas L Mann
Journal:  J Am Coll Cardiol       Date:  2020-08-11       Impact factor: 24.094

Review 4.  Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.

Authors:  Lorraine Lipscombe; Sonia Butalia; Kaberi Dasgupta; Dean T Eurich; Lori MacCallum; Baiju R Shah; Scot Simpson; Peter A Senior
Journal:  Can J Diabetes       Date:  2020-10       Impact factor: 4.190

5.  Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events.

Authors:  Theodore Wein; M Patrice Lindsay; David J Gladstone; Alexandre Poppe; Alan Bell; Leanne K Casaubon; Norine Foley; Shelagh B Coutts; Jafna Cox; James Douketis; Thalia Field; Laura Gioia; Jeffrey Habert; Eddy Lang; Shamir R Mehta; Christine Papoushek; William Semchuk; Mikul Sharma; Jacob A Udell; Stephanie Lawrence; Anita Mountain; Gord Gubitz; Dar Dowlatshahi; Anne Simard; Andrea de Jong; Eric E Smith
Journal:  CMAJ       Date:  2020-03-23       Impact factor: 8.262

6.  Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: A Meta-Analysis of Randomized Clinical Trials.

Authors:  Kris Kumar; Babikir Kheiri; Timothy F Simpson; Mohammed Osman; Hind Rahmouni
Journal:  Am J Med       Date:  2020-05-07       Impact factor: 4.965

7.  CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.

Authors:  Eileen O'Meara; Michael McDonald; Michael Chan; Anique Ducharme; Justin A Ezekowitz; Nadia Giannetti; Adam Grzeslo; George A Heckman; Jonathan G Howlett; Sheri L Koshman; Serge Lepage; Lisa M Mielniczuk; Gordon W Moe; Elizabeth Swiggum; Mustafa Toma; Sean A Virani; Shelley Zieroth; Sabe De; Sylvain Matteau; Marie-Claude Parent; Anita W Asgar; Gideon Cohen; Nowell Fine; Margot Davis; Subodh Verma; David Cherney; Howard Abrams; Abdul Al-Hesayen; Alain Cohen-Solal; Michel D'Astous; Diego H Delgado; Olivier Desplantie; Estrellita Estrella-Holder; Lee Green; Haissam Haddad; Karen Harkness; Adrian F Hernandez; Simon Kouz; Marie-Hélène LeBlanc; Douglas Lee; Frederick A Masoudi; Robert S McKelvie; Miroslaw Rajda; Heather J Ross; Bruce Sussex
Journal:  Can J Cardiol       Date:  2020-02       Impact factor: 5.223

8.  Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline.

Authors:  Kacie Doyle-Delgado; James J Chamberlain; Jay H Shubrook; Neil Skolnik; Jennifer Trujillo
Journal:  Ann Intern Med       Date:  2020-09-01       Impact factor: 25.391

9.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Authors:  Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins
Journal:  Eur Heart J       Date:  2021-02-01       Impact factor: 29.983

10.  Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.

Authors:  Javed Butler; Stefan D Anker; Gerasimos Filippatos; Muhammad Shahzeb Khan; João Pedro Ferreira; Stuart J Pocock; Nadia Giannetti; James L Januzzi; Ileana L Piña; Carolyn S P Lam; Piotr Ponikowski; Naveed Sattar; Subodh Verma; Martina Brueckmann; Waheed Jamal; Ola Vedin; Barbara Peil; Cordula Zeller; Faiez Zannad; Milton Packer
Journal:  Eur Heart J       Date:  2021-03-31       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.